Meetings - The ASCO Post

test

asd

By The ASCO Post Staff / breast cancer (1)

Hongchao Pan, PhD, on an Update on 5 Years of Endocrine Therapy for Early Breast Cancer

Hongchao Pan, PhD, of the University of Oxford, discusses an analysis of 86,000 women in the Early Breast Cancer Trialists’ Collaborative Group database, which showed that the risk of distant recurren...

breast cancer

By The ASCO Post Staff / breast cancer (1)

Ivana Sestak, PhD, on Clinical Treatment Score From TAILORx: Predicting Distant Breast Cancer Recurrence

Ivana Sestak, PhD, of Queen Mary University of London and the Centre for Cancer Prevention, discusses study findings that confirm the prognostic ability of the Clinical Treatment Score at 5 years (CTS...

breast cancer

By The ASCO Post Staff / breast cancer (1)

Hongchao Pan, PhD, on an Update on 5 Years of Endocrine Therapy for Early Breast Cancer

Hongchao Pan, PhD, of the University of Oxford, discusses an analysis of 86,000 women in the Early Breast Cancer Trialists’ Collaborative Group database, which showed that the risk of distant recurren...

breast cancer (1)

test

Hongchao Pan, PhD, on an Update on 5 Years of Endocrine Therapy for Early Breast Cancer

Ivana Sestak, PhD, on Clinical Treatment Score From TAILORx: Predicting Distant Breast Cancer Recurrence

Hongchao Pan, PhD, on an Update on 5 Years of Endocrine Therapy for Early Breast Cancer

Mirdametinib in Adults and Children With Symptomatic Neurofibromatosis Type 1–Associated Plexiform Neurofibroma

Genitourinary Cancer Expert Yuksel Urun, MD, Shares His Career Journey and the Importance of Achieving a Work/Life Balance

Overall Survival Not Improved With Maintenance Niraparib in Advanced Ovarian Cancer

At-Home Testing Kits Coordinated Outreach May Improve Colorectal Cancer Screening Rates

Peer Support Intervention May Help Improve Psychological Outcomes Among Patients With Cancer in Low-Resource Settings